AIBODY Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
AIBODY General Information
Description
Developer of a cloud-based digital physiology software designed to offer real-time, immersive medical simulations. The company's software provides detailed physiological responses to virtually any simulated medical condition or treatment protocol, enabling medical professionals to speed up human physiology teaching using the digital human body and other technology systems.
Contact Information
Website
www.aibody.ioCorporate Office
- 2-4 Sampson Street
- Wapping
- London E1W 1NA
- England, United Kingdom
Corporate Office
- 2-4 Sampson Street
- Wapping
- London E1W 1NA
- England, United Kingdom
AIBODY Timeline
AIBODY Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 11-Jun-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 19-Mar-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 18-Jan-2024 | $1.67M | Completed | Generating Revenue | ||
| 1. Seed Round | 19-Mar-2021 | $1.67M | $1.67M | Completed | Generating Revenue |
AIBODY Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AIBODY Patents
AIBODY Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026229978-A1 | System and method for digital modeling of biochemical processes | Pending | 29-Apr-2025 | ||
| WO-2026110144-A1 | System and method for digital modeling of cardiac cell membrane electrophysiology | Pending | 19-Nov-2024 | ||
| WO-2026110144-A9 | System and method for digital modeling of cardiac cell membrane electrophysiology | Pending | 19-Nov-2024 | ||
| WO-2026058254-A1 | Digital modeling of enzymatic function in biochemical reactions within cardiac cells | Pending | 10-Sep-2024 | ||
| EP-4812922-A1 | System and methods for computational simulation of the anatomical structures and intracardiac hemodynamics of heart with aortic valve disease in a patient | Pending | 21-Nov-2023 | G16H50/50 |
AIBODY Signals
AIBODY Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1991 Ventures | Accelerator/Incubator | Minority | ||
| Google Accelerator | Accelerator/Incubator | Minority | ||
| DigitalHealth.London Accelerator | Accelerator/Incubator | |||
| Northstar Ventures | Venture Capital | Minority | ||
| Raw Ventures | Venture Capital | Minority |
AIBODY FAQs
-
When was AIBODY founded?
AIBODY was founded in 2020.
-
Where is AIBODY headquartered?
AIBODY is headquartered in London, United Kingdom.
-
What is the size of AIBODY?
AIBODY has 29 total employees.
-
What industry is AIBODY in?
AIBODY’s primary industry is Other Healthcare Technology Systems.
-
Is AIBODY a private or public company?
AIBODY is a Private company.
-
What is AIBODY’s current revenue?
The current revenue for AIBODY is .
-
How much funding has AIBODY raised over time?
AIBODY has raised $7.5M.
-
Who are AIBODY’s investors?
1991 Ventures, Google Accelerator, DigitalHealth.London Accelerator, Northstar Ventures, and Raw Ventures have invested in AIBODY.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process